These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 7720083

  • 101. In vivo primary induction of virus-specific CTL by immunization with 9-mer synthetic peptides.
    Zhou X, Berg L, Motal UM, Jondal M.
    J Immunol Methods; 1992 Aug 30; 153(1-2):193-200. PubMed ID: 1517589
    [Abstract] [Full Text] [Related]

  • 102. Cyclic V3-loop-related HIV-1 conjugate vaccines. Synthesis, conformation and immunological properties.
    Tolman RL, Bednarek MA, Johnson BA, Leanza WJ, Marburg S, Underwood DJ, Emini EA, Conley AJ.
    Int J Pept Protein Res; 1993 May 30; 41(5):455-66. PubMed ID: 8320039
    [Abstract] [Full Text] [Related]

  • 103. Inhibition of human immunodeficiency virus type 1 infection and syncytium formation in human cells by V3 loop synthetic peptides from gp120.
    Nehete PN, Arlinghaus RB, Sastry KJ.
    J Virol; 1993 Nov 30; 67(11):6841-6. PubMed ID: 7692087
    [Abstract] [Full Text] [Related]

  • 104. Interleukin-12 is necessary for the priming of CD4+ T cells required during the elicitation of HIV-1 gp120-specific cytotoxic T-lymphocyte function.
    Gupta S, Boppana R, Mishra GC, Saha B, Mitra D.
    Immunology; 2008 Aug 30; 124(4):553-61. PubMed ID: 18298551
    [Abstract] [Full Text] [Related]

  • 105. Sculpted immunogens; B-cell epitope optimization using constrained secondary structure libraries.
    Urban J, Qabar M, Sia C, Klein M, Kahn M.
    Bioorg Med Chem; 1996 May 30; 4(5):673-6. PubMed ID: 8804532
    [Abstract] [Full Text] [Related]

  • 106.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 107.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 108. Linkage of a fusion peptide to a CTL epitope from the nucleoprotein of measles virus enables incorporation into ISCOMs and induction of CTL responses following intranasal immunization.
    Hsu SC, Schadeck EB, Delmas A, Shaw M, Steward MW.
    Vaccine; 1996 Aug 30; 14(12):1159-66. PubMed ID: 8911014
    [Abstract] [Full Text] [Related]

  • 109. A novel liposome-based adjuvant CAF01 for induction of CD8(+) cytotoxic T-lymphocytes (CTL) to HIV-1 minimal CTL peptides in HLA-A*0201 transgenic mice.
    Gram GJ, Karlsson I, Agger EM, Andersen P, Fomsgaard A.
    PLoS One; 2009 Sep 11; 4(9):e6950. PubMed ID: 19759892
    [Abstract] [Full Text] [Related]

  • 110. Strong augment effect of IL-12 expression plasmid on the induction of HIV-specific cytotoxic T lymphocyte activity by a peptide vaccine candidate.
    Hamajima K, Fukushima J, Bukawa H, Kaneko T, Tsuji T, Asakura Y, Sasaki S, Xin KQ, Okuda K.
    Clin Immunol Immunopathol; 1997 May 11; 83(2):179-84. PubMed ID: 9143379
    [Abstract] [Full Text] [Related]

  • 111. Induction of cross clade reactive specific antibodies in mice by conjugates of HGP-30 (peptide analog of HIV-1(SF2) p17) and peptide segments of human beta-2-microglobulin or MHC II beta chain.
    Zimmerman DH, Lloyd JP, Heisey D, Winship MD, Siwek M, Talor E, Sarin PS.
    Vaccine; 2001 Sep 14; 19(32):4750-9. PubMed ID: 11535326
    [Abstract] [Full Text] [Related]

  • 112. A chain section containing epitopes for cytotoxic T, B and helper T cells within a highly conserved region found in the human immunodeficiency virus type 1 Gag protein.
    Nakamura Y, Kameoka M, Tobiume M, Kaya M, Ohki K, Yamada T, Ikuta K.
    Vaccine; 1997 Apr 14; 15(5):489-96. PubMed ID: 9160516
    [Abstract] [Full Text] [Related]

  • 113. Mucosal immunity in mice immunized with HIV-1 peptide conjugated to Brucella abortus.
    Golding B, Eller N, Levy L, Beining P, Inman J, Matthews N, Scott DE, Golding H.
    Vaccine; 2002 Jan 31; 20(9-10):1445-50. PubMed ID: 11818165
    [Abstract] [Full Text] [Related]

  • 114. Immunization with recombinant protein: conditions for cytotoxic T cell and/or antibody induction.
    Bachmann MF, Hengartner H, Zinkernagel RM.
    Med Microbiol Immunol; 1994 Dec 31; 183(6):315-24. PubMed ID: 7596314
    [Abstract] [Full Text] [Related]

  • 115. Primary in vitro sensitization of human T-helper lymphocytes by peptides derived from the V3 loop of human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein.
    Billaud JN, Yagello M, Gluckman JC.
    Vaccine; 1994 Jan 31; 12(1):46-55. PubMed ID: 8303940
    [Abstract] [Full Text] [Related]

  • 116. Mucosal immunization with HIV-1 peptide vaccine induces mucosal and systemic cytotoxic T lymphocytes and protective immunity in mice against intrarectal recombinant HIV-vaccinia challenge.
    Belyakov IM, Derby MA, Ahlers JD, Kelsall BL, Earl P, Moss B, Strober W, Berzofsky JA.
    Proc Natl Acad Sci U S A; 1998 Feb 17; 95(4):1709-14. PubMed ID: 9465081
    [Abstract] [Full Text] [Related]

  • 117. Modification of delivery system enhances MHC nonrestricted immunogenicity of V3 loop region of HIV-1 gp120.
    Ahluwalia A, Gokulan K, Nath I, Rao DN.
    Microbiol Immunol; 1997 Feb 17; 41(10):779-84. PubMed ID: 9403501
    [Abstract] [Full Text] [Related]

  • 118. A phase I trial in HIV negative healthy volunteers evaluating the effect of potent adjuvants on immunogenicity of a recombinant gp120W61D derived from dual tropic R5X4 HIV-1ACH320.
    McCormack S, Tilzey A, Carmichael A, Gotch F, Kepple J, Newberry A, Jones G, Lister S, Beddows S, Cheingsong R, Rees A, Babiker A, Banatvala J, Bruck C, Darbyshire J, Tyrrell D, Van Hoecke C, Weber J.
    Vaccine; 2000 Jan 18; 18(13):1166-77. PubMed ID: 10649617
    [Abstract] [Full Text] [Related]

  • 119. Anti-gamma interferon antibodies enhance the immunogenicity of recombinant adenovirus vectors.
    Jackson SS, Schmitz JE, Letvin NL.
    Clin Vaccine Immunol; 2011 Nov 18; 18(11):1969-78. PubMed ID: 21900534
    [Abstract] [Full Text] [Related]

  • 120. Monopalmitic acid-peptide conjugates induce cytotoxic T cell responses against malarial epitopes: importance of spacer amino acids.
    Verheul AF, Udhayakumar V, Jue DL, Wohlhueter RM, Lal AA.
    J Immunol Methods; 1995 Jun 09; 182(2):219-26. PubMed ID: 7540640
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.